期刊文献+

Prognosis value of heat-shock proteins in esophageal and esophagogastric cancer:A systematic review and meta-analysis

下载PDF
导出
摘要 BACKGROUND Heat shock proteins(HSPs)are molecular chaperones that play an important role in cellular protection against stress events and have been reported to be overex-pressed in many cancers.The prognostic significance of HSPs and their regulatory factors,such as heat shock factor 1(HSF1)and CHIP,are poorly understood.AIM To investigate the relationship between HSP expression and prognosis in esophageal and esophagogastric cancer.METHODS A systematic review was conducted in accordance with PRISMA recommend-ations(PROSPERO:CRD42022370653),on Embase,PubMed,Cochrane,and LILACS.Cohort,case-control,and cross-sectional studies of patients with eso-phagus or esophagogastric cancer were included.HSP-positive patients were compared with HSP-negative,and the endpoints analyzed were lymph node metastasis,tumor depth,distant metastasis,and overall survival(OS).HSPs were stratified according to the HSP family,and the summary risk difference(RD)was calculated using a random-effect model.RESULTS The final selection comprised 27 studies,including esophageal squamous cell carcinoma(21),esophagogastric adenocarcinoma(5),and mixed neoplasms(1).The pooled sample size was 3465 patients.HSP40 and 60 were associated with a higher 3-year OS[HSP40:RD=0.22;95%confidence interval(CI):0.09-0.35;HSP60:RD=0.33;95%CI:0.17-0.50],while HSF1 was associated with a poor 3-year OS(RD=-0.22;95%CI:-0.32 to-0.12).The other HSP families were not associated with long-term survival.HSF1 was associated with a higher probability of lymph node metastasis(RD=-0.16;95%CI:-0.29 to-0.04).HSP40 was associated with a lower probability of lymph node dissemination(RD=0.18;95%CI:0.03-0.33).The expression of other HSP families was not significantly related to tumor depth and lymph node or distant metastasis.CONCLUSION The expression levels of certain families of HSP,such as HSP40 and 60 and HSF1,are associated with long-term survival and lymph node dissemination in patients with esophageal and esophagogastric cancer.
出处 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第4期1578-1595,共18页 世界胃肠肿瘤学杂志(英文版)(电子版)
  • 相关文献

参考文献2

二级参考文献21

  • 1Agorreta, J., Hu, J., Liu, D., Delia, D., Turley, H., Ferguson, D.J., lborra, E, Pajares, M.J., Larrayoz, M., Zudaire, 1., Pio, R., Montuenga, L.M., Harris, A.L., Garter, K., Pezzella, F., 2014. TRAPI regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Mol. Cancer Res. 12, 660-669.
  • 2Aust, S., Bachmayr-Heyda, A., Pateisky, E, Tong, D., Darb-Esfahani, S., Denkert, C., Chekerov, R., Sehouli, J., Mahner, S., Van Gorp, T., Vergote, 1., Speiser, E, Horvat, R., Zeillinger, R., Pils, D., 2012. Role of TRAPI and estrogen receptor alpha in patients with ovarian cancer - A study of the OVCAD consortium. Mol. Cancer 11, 69.
  • 3Brivanlou, A.H., Darnell Jr., J.E., 2002. Signal transduction and the control of gene expression. Science 295,813--818.
  • 4Costantino, E., Maddalena, E, Calise, S., Piscazzi, A., Tirino, V., Fersini, A., Ambrosi, A., Neri, V., Esposito, E, Landriscina, M., 2009. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and pro- tection from apoptosis in human colorectal carcinoma cells. Cancer Lett. 279, 39--46.
  • 5Gao, J.Y., Song, B.R., Peng, J.J., Lu, Y.M., 2012. Correlation between mito- chondrial TRAP-I expression and lymph node metastasis in colorectal cancer. World J. Gastroenterol. 18, 5965--5971.
  • 6Hsu, J.M., Chen, C.T., Chou, C.K., Kuo, H.E, Li, L.Y., Lin, C.Y., Lee, H.J., Wang, Y.N., Liu, M., Liao, H.W., Shi, B., Lai, C.C., Bedford, M.T., Tsai, C.H., Hung, M.C., 2011. Crosstalk between Arg 1175 methylation and Tyr 1173 pbosphorylafion negatively modulates EGFR-mediated ERK activation. Nat. Cell Biol. 13, 174--181.
  • 7Ira, C.N., Seo, J.S., 2014. Overexpression of tumor necrosis factor receptor- associated protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells. BMB Rep. 47, 280-285.
  • 8Landriscina, M., Amoroso, M.R., Piscazzi, A., Esposito, E, 2010. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol. Oncol. 117, 177--182.
  • 9Lear, I., Plescia, J., Goel, H.L., Li, J., Jiang, Z., Cohen, R.J., Languino, L.R., Altieri, D.C., 2010. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am. J. Pathol. 176, 393-401.
  • 10Maddalena, E, Sisinni, L., Lettini, G., Condelli, V., Matassa, D.S., Piscazzi, A., Amoroso, M.R., La Torte, G., Esposito, F., Landriscina, M., 2013. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitocbondrial antiapoptotic proteins by TRAPl. Mol. Oncol. 7, 895-906.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部